Latest News

Horizon Therapeutics plc Announces Changes in Research and Development Organization






DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth H.Z. Thompson, Ph.D., group vice president, clinical development and external search; Srini Ramanathan, Ph.D., group vice president, development sciences and San Francisco site head and Melanie Gloria, senior vice president, R&D operations, will report to Timothy Walbert, chairman, president and chief executive offi

Source link







Related posts

Global Stethoscope Market to 2026 – Industry Analysis, Trends, Market Size, and Forecasts – ResearchAndMarkets.com

Newsemia

Medical News Today: Study suggests avocados suppress hunger, but can we trust the research?

Newsemia

Luke Perry Dies of "Massive Stroke"

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy